fbpx

Day

juli 28, 2018
SAN DIEGO and COPENHAGEN, Denmark, July 23, 2018 /PRNewswire/ — Dermtreat, a clinical-stage biopharmaceutical company focused on mucosal diseases, today announced treatment of the first patient in a Phase 2b clinical trial of Rivelin® Clobetasol patch (Rivelin®-CLO) for oral lichen planus (OLP). Rivelin-CLO is the first biodegradable oral adhesive patch designed for local delivery of clobetasol...

Nyheder

Video: Mød fem professorer, der har viet deres hjerne til andres
14. maj 2020
300 obduktioner er kernen i nyt dansk corona-projekt
8. maj 2020
Nu kan du søge om at blive Lundbeckfonden fellow
5. maj 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge